The US Food and Drug Administration (FDA) has approved iptacopan (Fabhalta) as the first treatment to reduce proteinuria in ...

The extensive evidence supports the conclusion that the benefits vastly outweigh any minimal risks, positioning ProstaVive as ...

Paid Advertisement Methylene blue has gained widespread attention for its potential effects on focus, mood, and energy.

Scpharmaceuticals (($SCPH)) has held its Q4 earnings call. Read on for the main highlights of the call. The recent earnings call for ...

The company also anticipates opportunities for emergency use authorization in international markets before FDA approval. Tivic expects to leverage Entolimod for additional indications, including ...

Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

As nicotine pouches proliferate the market — and teen mouths — state lawmakers considered expanding the definition of tobacco ...

A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce federal regulations on compounded we ...

Novartis NVS announced that the FDA has approved Fabhalta (iptacopan) for a third indication. The regulatory body approved ...

The PSMA-PET imaging agent will be used for patients who have suspected metastasis and those with suspected cancer recurrence.

Heart disease patients now have another treatment option. The U.S. Food and Drug Administration has approved Alnylam ...

Gvoke VialDx is a concentrated liquid glucagon product. For diagnostic procedures, it works as a gastrointestinal motility inhibitor. The product is supplied as a single-dose vial containing 1mg of ...